The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Department of Neurology, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, China.
Transl Psychiatry. 2022 Aug 17;12(1):335. doi: 10.1038/s41398-022-02097-4.
This study examined the structural brain differences across individuals of different BD stages and the risks of developing bipolar disorder (BD) associated with these brain differences. A total of 221 participants who were recruited from the Guangzhou Brain Hospital and the community were categorized into four groups: NC (healthy control) (N = 77), high risk (HR) (N = 42), ultra-high risk (UHR) (N = 38), and bipolar disorder (BD) (N = 64) based on a list of criteria. Their demographics, clinical characteristics, and diffusion magnetic resonance imaging (dMRI) data were collected. ANCOVA results showed that the HR group had significantly reduced mean diffusivity (MD) (p = 0.043) and radial diffusivity (RD) (p = 0.039) of the left portico-ponto-cerebellar tracts when compared with the BD group. Moreover, logistic regression results showed that the specific diffusivity measures of cerebellar tracts (e.g., cortico-ponto-cerebellar tract), particularly the RD and MD revealed differences between groups at different BD stages after controlling for the covariates. The findings suggested that specific diffusivity (RD and MD) of cerebellar tracts (e.g., cortico-ponto-cerebellar tract) revealed differences between groups at different BD stages which is helpful in detecting the trajectory changes in BD syndromes in the early stages of BD, particularly when the BD syndromes start from HR stage.
这项研究考察了不同双相障碍(BD)阶段个体之间的大脑结构差异,以及这些大脑差异与发展为双相障碍的风险。共有 221 名参与者,他们来自广州脑科医院和社区,根据一系列标准分为四组:NC(健康对照组)(N=77)、高风险组(HR)(N=42)、超高风险组(UHR)(N=38)和双相障碍组(BD)(N=64)。收集了他们的人口统计学、临床特征和弥散磁共振成像(dMRI)数据。ANCOVA 结果显示,与 BD 组相比,HR 组左侧廊-桥-小脑束的平均弥散度(MD)(p=0.043)和径向弥散度(RD)(p=0.039)显著降低。此外,逻辑回归结果表明,在控制协变量后,小脑束(如皮质-桥-小脑束)的特定弥散度测量值(如 RD 和 MD)在不同 BD 阶段的组间存在差异。研究结果表明,小脑束(如皮质-桥-小脑束)的特定弥散度(RD 和 MD)在不同 BD 阶段的组间存在差异,有助于在 BD 综合征的早期阶段检测 BD 综合征的轨迹变化,尤其是当 BD 综合征从 HR 阶段开始时。